Who is Sypharma
Sypharma is a trusted CDMO partner, intelligently connecting the right insights, technology and expertise to bring extraordinary outcomes to healthcare.
Unlocking a
healthy future
Trusted CDMO Partner
We offer world leading full molecule-to-market manufacturing and scale-up support, throughout all phases from pre-clinical development to commercialization.
Sypharma partners with global biotech firms and apply our passion, dedication, and expertise to bring visions for a healthier world to life. Our dedication to quality is uncompromising and covers every stage of everything we do. Since 2005, Sypharma has been providing regulatory and contract manufacturing services for the manufacture of clinical trial and small-scale commercial products.
We offer world leading full molecule-to-market biologics manufacturing and scale-up support, throughout all phases from pre-clinical development through to commercialisation.
Our culture is about not only what we do,
but how we do it.
Our dedication to quality is uncompromising.
And it covers every stage of everything we do. From development, clinical supply, through to commercialization. Hundreds of organizations around the world trust Sypharma to fast track drug product development and delivery through every stage of the product life cycle.
Unlocking
speed
Re-Imagine your Clinical Development and Accelerate your journey with Sypharma Velocity.
The Australian Regulatory Framework is the fastest in the world for undertaking early phase research trials.
Combined with our ability to intelligently connect expert insights, world leading technology, and specialised capabilities with agility and speed. To optimize every link in the chain and achieve faster results, accelerating decisions and delivering life-changing therapies sooner.
Balancing speed, risk and cost through custom solutions, by leveraging our bioprocessing technologies and process development.
We understand change in inevitable in a product lifecycle and strive to make changes happen without risking speed to market.
Take advantage
of the Sypharma difference.
Clinical trials safety monitoring and reporting is vital to ensure participant safety, data integrity and regulatory compliance.
Sypharma’s state-of-the-art built-for-purpose technology facilitates the management, reporting, and analysis of key safety information throughout trials.
Our services ensure regulatory compliance, and monitoring of the study drug safety profile to identify, evaluate and minimize safety-related risks at a reasonable cost.
Unlocking
Advantages
Manufacturing in Australia presents numerous financial incentives to biotech companies large and small.
The streamlined approach in government regulation allows companies to save significantly on clinical trial related costs. In addition, the Australian government offers considerable tax benefits for companies conducting research and development domestically.
Depending on its size, your company may be eligible for up to a 43.5% tax credit on R&D expenditure including clinical trials, analytics and study drug manufacture.
The Australian regulatory body for clinical trials, the Therapeutic Goods Administration, offers two schemes for conducting clinical trials in Australia; the CTN Scheme and the CTX Scheme.
Our passion is to transform great ideas into life changing products. We seek to do things better, simpler, faster to keep Sypharma and our partners at the forefront of the field.
Unlocking resources
Collaboration & Potential
We work together with innovative biotech developers to your drug production destination means the world to us, and our dedicated team of experts will support and guide you from the earliest stage of development through commercialization and beyond.
